Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,893−100.0%Sold outHolders
Q1 20261,893$76.2K<0.1%+201+11.9%AddedHolders
Q4 20251,692$42.5K<0.1%−278−14.1%ReducedHolders
Q3 20251,970$44.6K<0.1%+46+2.4%AddedHolders
Q2 20251,924$33.3K<0.1%+855+80.0%AddedHolders
Q1 20251,069$23.4K<0.1%+332+45.0%AddedHolders
Q4 2024737$23.5K<0.1%−1,142−60.8%ReducedHolders
Q3 20241,879$54.2K<0.1%+250+15.3%AddedHolders
Q2 20241,629$62.5K<0.1%+88+5.7%AddedHolders
Q1 20241,541$90.6K<0.1%+44+2.9%AddedHolders
Q4 20231,497$89.6K<0.1%+71+5.0%AddedHolders
Q3 20231,426$54.2K<0.1%+470+49.2%AddedHolders
Q2 2023956$87.1K<0.1%+14+1.5%AddedHolders
Q1 2023942$62.1K<0.1%+868+1,173.0%AddedHolders
Q4 202274$3.83K<0.1%−7−8.6%ReducedHolders
Q3 202281$6.00K<0.1%+7+9.5%AddedHolders
Q2 202274$3.00K<0.1%−56−43.1%ReducedHolders
Q1 2022130$6.00K<0.1%−2−1.5%ReducedHolders
Q4 2021132$6.00K<0.1%+73+123.7%AddedHolders
Q3 202159$2.00K<0.1%00.0%UnchangedHolders
Q2 202159$4.00K<0.1%00.0%UnchangedHolders
Q1 202159$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.